HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways.

Abstract
Fine-tuning of cytokine-inducing pathways is essential for immune homeostasis. Consistently, a dysregulated increase or decrease in pattern-recognition receptor (PRR)-induced signaling and cytokine secretion can lead to inflammatory bowel disease. Multiple gene loci are associated with inflammatory bowel disease, but their functional effects are largely unknown. One such region in chromosome 2q12 (rs917997), also associated with other immune-mediated diseases, encompasses IL18RAP. We found that human monocyte-derived macrophages (MDMs) from rs917997 AA risk carriers secrete significantly less cytokines than G carriers upon stimulation of multiple PRRs, including nucleotide-binding oligomerization domain 2 (NOD2). We identified that IL-18 signaling through IL-18RAP was critical in amplifying PRR-induced cytokine secretion in MDMs. IL-18RAP responded to NOD2-initiated early, caspase-1-dependent autocrine IL-18, which dramatically enhanced MAPK, NF-κB, PI3K, and calcium signaling. Reconstituting MAPK activation was sufficient to rescue decreased cytokines in NOD2-stimulated IL-18RAP-deficient MDMs. Relative to GG carriers, MDM from rs917997 AA carriers had decreased expression of cell-surface IL-18RAP protein, as well as of IL-18R1 and IL-1R1, genes also located in the IL18RAP region. Accordingly, these risk-carrier MDMs show diminished PRR-, IL-18-, and IL-1-induced MAPK and NF-κB signaling. Taken together, our results demonstrate clear functional consequences of the rs917997 risk polymorphism; this polymorphism leads to a loss-of-function through decreased IL-18RAP, IL-18R1, and IL-1R1 protein expression, which impairs autocrine IL-18 and IL-1 signaling, thereby leading to decreased cytokine secretion in MDMs upon stimulation of a broad range of PRRs.
AuthorsMatija Hedl, Shasha Zheng, Clara Abraham
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 192 Issue 12 Pg. 5924-32 (Jun 15 2014) ISSN: 1550-6606 [Electronic] United States
PMID24842757 (Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2014 by The American Association of Immunologists, Inc.
Chemical References
  • IL18R1 protein, human
  • IL18RAP protein, human
  • IL1R1 protein, human
  • Interleukin-18
  • Interleukin-18 Receptor alpha Subunit
  • Interleukin-18 Receptor beta Subunit
  • NF-kappa B
  • Receptors, Interleukin-1 Type I
  • Phosphatidylinositol 3-Kinases
  • Extracellular Signal-Regulated MAP Kinases
Topics
  • Autocrine Communication (genetics, immunology)
  • Calcium Signaling (genetics, immunology)
  • Chromosomes, Human, Pair 2 (genetics, immunology)
  • Extracellular Signal-Regulated MAP Kinases (genetics, immunology)
  • Female
  • Gene Expression Regulation (genetics, immunology)
  • Humans
  • Inflammatory Bowel Diseases (genetics, immunology)
  • Interleukin-18 (genetics, immunology)
  • Interleukin-18 Receptor alpha Subunit (genetics, immunology)
  • Interleukin-18 Receptor beta Subunit (genetics, immunology)
  • MAP Kinase Signaling System (genetics, immunology)
  • Macrophages (immunology)
  • Male
  • NF-kappa B (genetics, immunology)
  • Phosphatidylinositol 3-Kinases (genetics, immunology)
  • Polymorphism, Single Nucleotide (immunology)
  • Receptors, Interleukin-1 Type I (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: